Cite
HARVARD Citation
He, M. et al. (2020). 60 mg dose ticagrelor provides stronger platelet inhibition than clopidogrel in Chinese patients with chronic coronary syndrome: A randomized, single-blind, crossover study. Thrombosis research. pp. 60-61. [Online].